Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Discontinuation of Low Dose Levothyroxine Therapy for Older Adults With Subclinical Hypothyroidism
NCT07787585Phase 4Not yet recruiting
- Start
- Oct 2027
- Primary completion
- Sep 2030
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levothyroxine sodium in hypothyroidism (2 arms). Primary endpoint: ThyPRO Hypothyroid Symptoms Scale at 6 months. Planned start Oct 2027; status: not yet recruiting.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT07787585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07787585.